Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PETX | ARATANA THERAPEUTICS, INC. | Vander Vort John | Director | Mar 06, 2015 | Sale | $20.01 | 6,137 | 122,776 | 25,000 | Mar 06, 2015, 06:31 PM | |
CNAT | Conatus Pharmaceuticals Inc | Vander Vort John | 10% Owner | Jul 30, 2013 | Option Exercise | $11.00 | 181,981 | 2,001,791 | 1,192,080 | Aug 01, 2013, 02:19 PM | |
PETX | ARATANA THERAPEUTICS, INC. | Vander Vort John | Director | Jul 02, 2013 | Buy | $6.00 | 500,000 | 3,000,000 | 4,351,050 | Jul 02, 2013, 05:08 PM | |
PCRX | Pacira Pharmaceuticals, Inc. | Vander Vort John | Former 10% Owner | Mar 11, 2013 | Sale | $27.86 | 500,000 | 13,930,000 | 2,790,479 | Mar 13, 2013, 12:31 PM | |
PCRX | Pacira Pharmaceuticals, Inc. | Vander Vort John | 10% Owner | Nov 21, 2011 | Buy | $6.50 | 461,538 | 2,999,997 | 3,290,479 | Nov 22, 2011, 02:04 PM | |
PCRX | Pacira Pharmaceuticals, Inc. | Vander Vort John | 10% Owner | Feb 08, 2011 | Buy | $7.00 | 535,714 | 3,749,998 | 2,828,941 | Feb 17, 2011, 02:58 PM | |
PCRX | Pacira Pharmaceuticals, Inc. | Vander Vort John | 10% Owner | Feb 08, 2012 | Buy | $7.00 | 535,714 | 3,749,998 | 2,828,941 | Feb 10, 2011, 04:27 PM |